Wolf Group Capital Advisors Acquires Shares of 3,450 Edwards Lifesciences Corporation (NYSE:EW)
MarketBeat
Wolf Group Capital Advisors acquired a new stake in Edwards Lifesciences Corporation (NYSE:EW - Free Report) in the 1st quarter, according to the company in its most recent filing with the SEC. The fund acquired 3,450 shares of the medical research company's stock, valued at approximately $250,000.
NYSE:EW